(Q84628841)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

P A Thompson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

H M Prince

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

J F Seymour

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

D Ritchie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K Stokes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K Burbury

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Wolf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

S Peinert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

T Joyce

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

2 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

764-765

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20676149%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.180

9 February 2020

exact match

0 references

cites work

The role of complete response in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

Treatment of acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

The proteasome--an emerging therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.180

7 January 2021